NO20005312L - Stabile sammensetninger som omfatter levosimendan og alginsyre - Google Patents

Stabile sammensetninger som omfatter levosimendan og alginsyre

Info

Publication number
NO20005312L
NO20005312L NO20005312A NO20005312A NO20005312L NO 20005312 L NO20005312 L NO 20005312L NO 20005312 A NO20005312 A NO 20005312A NO 20005312 A NO20005312 A NO 20005312A NO 20005312 L NO20005312 L NO 20005312L
Authority
NO
Norway
Prior art keywords
levosimendan
alginic acid
stable compositions
compositions
stable
Prior art date
Application number
NO20005312A
Other languages
English (en)
Other versions
NO20005312D0 (no
NO318575B1 (no
Inventor
Ilkka Larma
Maarit Baeckman
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20005312D0 publication Critical patent/NO20005312D0/no
Publication of NO20005312L publication Critical patent/NO20005312L/no
Publication of NO318575B1 publication Critical patent/NO318575B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20005312A 1998-04-23 2000-10-20 Stabile sammensetninger som omfatter levosimendan og alginsyre NO318575B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980902A FI980902A7 (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia
PCT/FI1999/000331 WO1999055337A1 (en) 1998-04-23 1999-04-23 Stabile compositions comprising levosimendan and alginic acid

Publications (3)

Publication Number Publication Date
NO20005312D0 NO20005312D0 (no) 2000-10-20
NO20005312L true NO20005312L (no) 2000-11-21
NO318575B1 NO318575B1 (no) 2005-04-11

Family

ID=8551576

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005312A NO318575B1 (no) 1998-04-23 2000-10-20 Stabile sammensetninger som omfatter levosimendan og alginsyre

Country Status (32)

Country Link
US (1) US6531458B1 (no)
EP (1) EP1079834B1 (no)
JP (1) JP4475809B2 (no)
KR (1) KR100590622B1 (no)
CN (1) CN1165309C (no)
AT (1) ATE231395T1 (no)
AU (1) AU756338B2 (no)
BG (1) BG64766B1 (no)
BR (1) BR9909867A (no)
CA (1) CA2329232C (no)
CZ (1) CZ290911B6 (no)
DE (1) DE69905034T2 (no)
DK (1) DK1079834T3 (no)
EA (1) EA002428B1 (no)
EE (1) EE04143B1 (no)
ES (1) ES2191426T3 (no)
FI (1) FI980902A7 (no)
GE (1) GEP20032942B (no)
HR (1) HRP20000703B1 (no)
HU (1) HUP0105446A3 (no)
ID (1) ID26650A (no)
IL (2) IL138950A0 (no)
MX (1) MXPA00010368A (no)
NO (1) NO318575B1 (no)
NZ (1) NZ507455A (no)
PL (1) PL192274B1 (no)
PT (1) PT1079834E (no)
RS (1) RS49955B (no)
SK (1) SK284600B6 (no)
TR (1) TR200003101T2 (no)
WO (1) WO1999055337A1 (no)
ZA (1) ZA200005630B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
JPWO2002064120A1 (ja) * 2001-02-13 2004-06-10 大正製薬株式会社 内服ゲル製剤
JP2008533109A (ja) * 2005-03-14 2008-08-21 オリオン コーポレーション 利尿を促進するための複合治療
PT3370693T (pt) * 2015-11-06 2020-04-08 Carinopharm Gmbh Formulações melhoradas de levossimendano para administração intravenosa como infusão ou injeção e de concentrado de infusão
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
NZ203684A (en) * 1982-04-05 1986-06-11 Merck Sharp & Dohme Granular formulation for the stabilization of unstable drugs or food supplements
EP0123291A2 (en) 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
US4716042A (en) * 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A7 (fi) 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia

Also Published As

Publication number Publication date
CA2329232A1 (en) 1999-11-04
EA002428B1 (ru) 2002-04-25
JP4475809B2 (ja) 2010-06-09
EA200001097A1 (ru) 2001-04-23
DE69905034D1 (de) 2003-02-27
ID26650A (id) 2001-01-25
ES2191426T3 (es) 2003-09-01
NO20005312D0 (no) 2000-10-20
YU64000A (sh) 2002-12-10
US6531458B1 (en) 2003-03-11
HUP0105446A3 (en) 2002-09-30
EE200000616A (et) 2002-06-17
SK284600B6 (sk) 2005-07-01
PL343722A1 (en) 2001-09-10
HRP20000703B1 (hr) 2009-11-30
PT1079834E (pt) 2003-04-30
BG104958A (bg) 2001-07-31
FI980902A0 (fi) 1998-04-23
HRP20000703A2 (en) 2001-04-30
SK15552000A3 (sk) 2001-05-10
WO1999055337A1 (en) 1999-11-04
MXPA00010368A (es) 2002-07-02
DE69905034T2 (de) 2003-09-04
EE04143B1 (et) 2003-10-15
JP2002512964A (ja) 2002-05-08
CZ20003779A3 (en) 2001-05-16
RS49955B (sr) 2008-09-29
CN1165309C (zh) 2004-09-08
EP1079834B1 (en) 2003-01-22
TR200003101T2 (tr) 2001-01-22
NZ507455A (en) 2002-02-01
CN1298303A (zh) 2001-06-06
ZA200005630B (en) 2002-01-14
PL192274B1 (pl) 2006-09-29
CA2329232C (en) 2007-10-30
HK1031998A1 (en) 2001-07-06
ATE231395T1 (de) 2003-02-15
FI980902A7 (fi) 1999-10-24
BG64766B1 (bg) 2006-03-31
IL138950A0 (en) 2001-11-25
BR9909867A (pt) 2000-12-19
AU3524899A (en) 1999-11-16
CZ290911B6 (cs) 2002-11-13
GEP20032942B (en) 2003-04-25
KR100590622B1 (ko) 2006-06-19
IL138950A (en) 2006-08-20
HUP0105446A2 (hu) 2002-07-29
EP1079834A1 (en) 2001-03-07
NO318575B1 (no) 2005-04-11
DK1079834T3 (da) 2003-04-07
AU756338B2 (en) 2003-01-09
KR20010072577A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
CY1112310T1 (el) Προφαρμακα κομπρεταστατινης α1-φωσφορικης και κομπρεταστατινης β1-φωσφορικης
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
EA200300906A1 (ru) Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7
ATE273690T1 (de) Zusammensetzung zur hautdesinfizierung
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
BR9908280A (pt) Inibidores de enzimas de fosfolipase
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
ATE350375T1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
DE60143906D1 (de) Verwendung von derivaten der 2-oxothiazolidin-4-corbonsäure als prä-abschuppungsmittel
FI970430L (fi) Atsa-asparaziinihappo analogeja 1-beta-interleukiinia muuttavan entsyymin inhibiittoreina
BR9810450A (pt) Derivados de ácido barbitúrico com atividade antimetastática e antitumor
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK1112067T3 (da) Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromer
TR199802441A3 (tr) Kanda asiri ürik asit bulunmasinin tedavisi ve önlenmesi için yöntem ve terkip.
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
NO20005312D0 (no) Stabile sammensetninger som omfatter levosimendan og alginsyre
ATE139226T1 (de) Aminosulfonylharnstoff-acat-inhibitoren
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
NO20003758L (no) Trekonserveringsmidler
DK0921806T3 (da) Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser
TR200200278T2 (tr) Kalsilitik bileşimler
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
ATE238791T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum
DE60034770D1 (de) Stabile fumagillin-formulierung
DE60137506D1 (de) Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees